CN Patent

CN107837395A — 冻干制剂

Assigned to SmithKline Beecham Corp · Expires 2018-03-27 · 8y expired

What this patent protects

本发明涉及生产多肽组合物的方法，该方法包括：将多肽与挥发性添加剂混合以形成液体混合物和将该液体混合物冻干以获得冻干的多肽组合物。

USPTO Abstract

本发明涉及生产多肽组合物的方法，该方法包括：将多肽与挥发性添加剂混合以形成液体混合物和将该液体混合物冻干以获得冻干的多肽组合物。

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN107837395A
Jurisdiction: CN
Classification: —
Expires: 2018-03-27
Drug substance claim: No
Drug product claim: No
Assignee: SmithKline Beecham Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.